1. Home
  2. IPW vs RFL Comparison

IPW vs RFL Comparison

Compare IPW & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPW
  • RFL
  • Stock Information
  • Founded
  • IPW 2018
  • RFL 2017
  • Country
  • IPW United States
  • RFL United States
  • Employees
  • IPW N/A
  • RFL N/A
  • Industry
  • IPW Catalog/Specialty Distribution
  • RFL Real Estate
  • Sector
  • IPW Consumer Discretionary
  • RFL Finance
  • Exchange
  • IPW Nasdaq
  • RFL Nasdaq
  • Market Cap
  • IPW 29.3M
  • RFL 55.3M
  • IPO Year
  • IPW 2021
  • RFL N/A
  • Fundamental
  • Price
  • IPW $0.86
  • RFL $1.92
  • Analyst Decision
  • IPW Strong Buy
  • RFL
  • Analyst Count
  • IPW 1
  • RFL 0
  • Target Price
  • IPW $2.75
  • RFL N/A
  • AVG Volume (30 Days)
  • IPW 195.5K
  • RFL 27.8K
  • Earning Date
  • IPW 02-12-2025
  • RFL 12-27-2024
  • Dividend Yield
  • IPW N/A
  • RFL N/A
  • EPS Growth
  • IPW N/A
  • RFL N/A
  • EPS
  • IPW N/A
  • RFL N/A
  • Revenue
  • IPW $78,571,632.00
  • RFL $697,000.00
  • Revenue This Year
  • IPW $8.31
  • RFL N/A
  • Revenue Next Year
  • IPW $77.15
  • RFL N/A
  • P/E Ratio
  • IPW N/A
  • RFL N/A
  • Revenue Growth
  • IPW N/A
  • RFL 151.62
  • 52 Week Low
  • IPW $0.40
  • RFL $1.29
  • 52 Week High
  • IPW $3.65
  • RFL $2.50
  • Technical
  • Relative Strength Index (RSI)
  • IPW 44.81
  • RFL 53.58
  • Support Level
  • IPW $0.78
  • RFL $1.71
  • Resistance Level
  • IPW $1.02
  • RFL $1.92
  • Average True Range (ATR)
  • IPW 0.12
  • RFL 0.10
  • MACD
  • IPW 0.02
  • RFL -0.00
  • Stochastic Oscillator
  • IPW 32.78
  • RFL 84.00

About IPW iPower Inc.

iPower Inc is online hydroponic equipment and accessory retailer and supplier in North America. The company sells products through own website as well as online channel partners that include Amazon, Walmart, and eBay.

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

Share on Social Networks: